Post-Transplant and In-Hospital Risk Factors for ARDS After Hematopoietic Stem Cell Transplantation

被引:3
|
作者
Herasevich, Svetlana [1 ]
Frank, Ryan [2 ]
Hogan, William J. [3 ]
Alkhateeb, Hassan [3 ]
Limper, Andrew H. [4 ]
Gajic, Ognjen [4 ]
Yadav, Hemang [4 ,5 ]
机构
[1] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA
[2] Mayo Clin, Div Hlth Sci Res Biomed Stat & Informat, Rochester, MN USA
[3] Mayo Clin, Div Hematol, Rochester, MN USA
[4] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA
[5] Mayo Clin, Div Pulm & Crit Care Med, 200 1st St SW, Rochester, MN 55905 USA
关键词
ARDS; bone marrow trans- plant; hematopoietic stem cell transplantation; respiratory failure; ICU; immunocompromised host; RESPIRATORY-DISTRESS-SYNDROME; INJURY PREDICTION SCORE; PULMONARY COMPLICATIONS; EPIDEMIOLOGY; MORTALITY; OUTCOMES;
D O I
10.4187/respcare.10224
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: ARDS is a serious complication of hematopoietic stem cell transplant (HSCT). Pre-transplant risk factors for developing ARDS after HSCT have been recently identified. The objective of this study was to better understand post-transplant risk factors for developing ARDS after HSCT. METHODS: This was a nested case-control study. ARDS cases were matched to hospitalized non-ARDS controls by age, type of transplantation (allogeneic vs autologous), and time from transplantation. In a conditional logistic regression model, any potential risk factors were adjusted a priori for risk factors known to be associated with ARDS development. RESULTS: One hundred and seventy ARDS cases were matched 1:1 to non-ARDS hospitalized controls. Pre-admission, cases were more likely to be on steroids (odds ratio [OR] 1.90 [1.13- 3.19], P = .02). At time of admission, cases had lower platelet count (OR 0.95 [0.91-0.99], P = .02), lower bicarbonate (OR 0.94 [0.88-0.99], P = .035), and higher creatinine (OR 1.91 [1.23- 2.94], P = .004). During the first 24 h after admission, cases were more likely to have received transfusion (OR 2.41 [1.48-3.94], P < .001), opioids (OR 2.94 [1.67-5.18], P < .001), and have greater fluid administration (OR 1.52 [1.30-1.78], P < .001). During the hospitalization, ARDS cases had higher temperature (OR 1.77 [1.34-2.33], P < .001) and higher breathing frequency (OR 1.52 [1.33-1.74], P < .001). ARDS cases were more likely to have had sepsis (OR 68.0 [15.2- 301.7], P < .001), bloodstream infection (OR 4.59 [2.46-8.57], P < .001), and pneumonia (OR 9.76 [5.01-19.00], P < .001). CONCLUSIONS: Several post-transplant predictors of ARDS development specific to the HSCT population were identified in the pre-hospital and early in-hospital domains. These findings can provide insights into causal mechanisms of ARDS development and be used to develop HSCT-specific risk prediction models.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 50 条
  • [1] Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation
    Fujimoto, Ayumi
    Hiramoto, Nobuhiro
    Yamasaki, Satoshi
    Inamoto, Yoshihiro
    Uchida, Naoyuki
    Maeda, Tetsuo
    Mori, Takehiko
    Kande, Yoshinobu
    Kondo, Tadakazu
    Shiratori, Souichi
    Miyakoshi, Shigesaburo
    Ishiyama, Ken
    Ikegame, Kazuhiro
    Matsuhashi, Yoshiko
    Tanaka, Junji
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Ogata, Masao
    Suzuki, Ritsuro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1441 - 1449
  • [2] Risk Factors and Predictive Scoring System for Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation
    Fujimoto, Ayumi
    Hiramoto, Nobuhiro
    Yamasaki, Satoshi
    Inamoto, Yoshihiro
    Uchida, Naoyuki
    Maeda, Tetsuo
    Mori, Takehiko
    Kanda, Yoshinobu
    Kondo, Tadakazu
    Tanaka, Junji
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Ogata, Masao
    Suzuki, Ritsuro
    BLOOD, 2018, 132
  • [3] The risk factors of post-transplant lymphoproliferative disorders following haploidentical hematopoietic stem cell transplantation
    张春丽
    China Medical Abstracts (Internal Medicine), 2014, 31 (03) : 188 - 188
  • [4] Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation
    Kalra, Amit
    Roessner, Cameron
    Jupp, Jennifer
    Williamson, Tyler
    Tellier, Raymond
    Chaudhry, Ahsan
    Khan, Faisal
    Taparia, Minakshi
    Jimenez-Zepeda, Victor H.
    Stewart, Douglas A.
    Daly, Andrew
    Storek, Jan
    CLINICAL TRANSPLANTATION, 2018, 32 (01)
  • [5] Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation
    Kinzel, Megan
    Dowhan, Michelle
    Kalra, Amit
    Williamson, Tyler S.
    Dabas, Rosy
    Jamani, Kareem
    Chaudhry, Ahsan
    Shafey, Mona
    Jimenez-Zepeda, Victor
    Duggan, Peter
    Daly, Andrew
    Dharmani-Khan, Poonam
    Khan, Faisal
    Storek, Jan
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (01): : 53.e1 - 53.e10
  • [6] Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation
    Romero, Samuel
    Montoro, Juan
    Guinot, Marta
    Almenar, Luis
    Andreu, Rafael
    Balaguer, Aitana
    Beneyto, Isabel
    Espi, Jordi
    Gomez-Codina, Jose
    Iacoboni, Gloria
    Jarque, Isidro
    Lopez-Andujar, Rafael
    Mayordomo-Aranda, Empar
    Montalar, Joaquin
    Pastor, Amparo
    Pastor, Miguel
    Pinana, Jose L.
    Rojas-Ferrer, Nohelia
    Sanchez-Lazaro, Ignacio
    Sandoval, Jesus
    Sanz, Guillermo
    Sanz, Miguel A.
    Sole, Amparo
    Sanz, Jaime
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 142 - 150
  • [7] Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Hebert, Courtney
    Watts, Nicole
    Isaac, Shiney
    Kukkamalla, Rivvi
    Jamy, Omer
    Saad, Ayman
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S276 - S277
  • [8] Haploidentical Hematopoietic Stem Cell Transplantation with post-transplant Cyclophosphamide for Osteopetrosis
    Even-Or, Ehud
    Zaidman, Irina
    Stepensky, Polina
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 391 - 391
  • [9] Spousal Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse/Rejection
    Ikegame, Kazuhiro
    Kaida, Katsuji
    Ishii, Shinichi
    Yoshihara, Satoshi
    Taniguchi, Kyoko
    Inoue, Takayuki
    Tamaki, Hiroya
    Okada, Masaya
    Soma, Toshihiro
    Ogawa, Hiroyasu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S158 - S159
  • [10] OVERVIEW OF POST-TRANSPLANT MONITORING IN PATIENTS AFTER HAPLOIDENTICAL ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Cechova, Hana
    Pegova, Kristyna
    Pavlatova, Lucie
    Zizkova, Radka
    Hrabakova, Pavla
    Prerovska, Renata
    Stankova, Martina
    Brezinova, Dagmar
    HLA, 2018, 91 (05) : 403 - 404